Bitcoin's market cap crossed $1.63T, surpassing Tesla and returning to the top 15 global assets — up 5% over 24 hours. The BOJ hiked to a 31-year high of 1.25% but the yen fell to 157.80 anyway as two board members dissented and guidance stayed vague — keeping carry trade funding cheap and removing the risk-off signal a hike was supposed to deliver. Morgan Stanley's MSBT ran 20 consecutive sessions without a single outflow day through one of the most volatile months of the year. XRP exchange reserves hit a 7-year low. The 21Shares Injective ETF amended its S-1, joining the growing queue of altcoin ETF filings.Bitcoin Market Cap Tops Tesla, Returns to Top 15 Global AssetsBitcoin's market cap reached $1.63T — surpassing Tesla's $1.438T (closed Friday at $364.27, -0.53%) — and returning to the top 15 global assets. The 5% 24-hour gain came against a week that delivered the Fed's first hike since July 2023, a CLARITY Act failure, oil at $106, and a BOJ hike. Blockware's Mitchell Askew's seller exhaustion read holds: Bitcoin is down just 1.5% in September — its historically worst month — after absorbing four simultaneous macro headwinds. Above price, 8% of supply was acquired between $80,000-$82,000 with the 50-week moving average at $81,081 — the ceiling that hasn't been cleared since September 4. Morgan Stanley's Bitcoin ETF Has Gone 20 Sessions Without an Outflow DayMSBT accumulated ~$51.5M over 20 consecutive sessions without a single redemption day — roughly $2.6M per session. The amount is a fraction of the $99.5B complex, but the consistency through a month that included a $731M single-day inflow, a $450M single-day outflow, and the CLARITY Act collapse is the signal. Steady, schedule-driven flows through volatility point to advisory or model-driven allocation rather than discretionary trading — consistent with Morgan Stanley's wealth management distribution. Bitcoin ETFs remain ~$1B negative year-to-date despite August's $3.52B surge, with the fee gap between GBTC's 1.50% and IBIT's 0.25% still the primary driver of complex-wide flow composition.The Yen Fell 1.2% to 157.80 in the Session After the BOJ Raised RatesThe BOJ hiked to 1.25% by a 7-2 vote — two dovish dissenters (Asada, Sato) — and the yen promptly fell to 157.80 rather than strengthening. SMBC's Hirofumi Suzuki: "The two dissenting votes conveyed a dovish impression and tempered expectations for further hikes." A currency weakening on a rate hike means the hike was fully priced and/or read as insufficient. For crypto, yen weakness at 157.80 keeps carry trade funding cheap — supportive for risk assets, opposite of what a hike typically delivers. European indices fell across the board (Euro Stoxx 50 -1.22%, FTSE -1.03%, DAX -0.94%). Silver outpaced gold 6-to-1: +2.32% to $66.47 vs gold's +0.36% to $4,364.SEC Receives Amended S-1/A for 21Shares Injective ETF as Altcoin ETF Race Heats UpThe SEC received an amended S-1/A for the 21Shares Injective ETF (proposed ticker: TINJ on Nasdaq), updating an October 2025 original filing. INJ staking rewards ranged from 9.3%-13.62% annually in 2025 — a yield dimension most equity ETFs cannot match. INJ's market cap sits at ~$488M, meaning even modest ETF inflows could represent a meaningful share of float. 21Shares already offers an INJ staking ETP in Europe. The filing joins a growing queue of altcoin ETF registrations covering SOL, XRP, LTC, ADA, and DeFi tokens since spot Bitcoin ETFs launched in January 2024. Custody arrangements remain unfinalized — a detail the SEC will want resolved before any approval.XRP Spot ETFs Record $5.15 Million Outflow as Exchange Reserves Hit Seven-Year LowXRP spot ETFs recorded a $5.15M outflow Thursday while remaining $9.60M positive for the week — with a 10th consecutive week of net inflows possible if Friday's data doesn't exceed that figure. More structurally significant: XRP exchange reserves fell to a 7-year low near 1.7B XRP. Low exchange reserves mean less immediately available selling inventory — the same supply squeeze dynamic that preceded Bitcoin's August breakout. CME's XRP futures share rose to 17% from 10% in mid-August as institutional positioning built on regulated venues. The CLARITY Act's failure removed the near-term legislative catalyst, but SEC and CFTC rulemaking under existing authority remains the open regulatory pathway.